These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 11699891

  • 21. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.
    Costello E, Munoz M, Buetti E, Meylan PR, Diggelmann H, Thali M.
    Gene Ther; 2000 Apr; 7(7):596-604. PubMed ID: 10819575
    [Abstract] [Full Text] [Related]

  • 22. Viral gene therapy strategies: from basic science to clinical application.
    Young LS, Searle PF, Onion D, Mautner V.
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [Abstract] [Full Text] [Related]

  • 23. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
    Dupuy FP, Mouly E, Mesel-Lemoine M, Morel C, Abriol J, Cherai M, Baillou C, Nègre D, Cosset FL, Klatzmann D, Lemoine FM.
    J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
    [Abstract] [Full Text] [Related]

  • 24. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation.
    Mostoslavsky G, Kotton DN, Fabian AJ, Gray JT, Lee JS, Mulligan RC.
    Mol Ther; 2005 Jun; 11(6):932-40. PubMed ID: 15922964
    [Abstract] [Full Text] [Related]

  • 25. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos.
    Pfeifer A, Ikawa M, Dayn Y, Verma IM.
    Proc Natl Acad Sci U S A; 2002 Feb 19; 99(4):2140-5. PubMed ID: 11854510
    [Abstract] [Full Text] [Related]

  • 26. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I.
    Ann N Y Acad Sci; 2005 Feb 19; 1054():78-91. PubMed ID: 16339654
    [Abstract] [Full Text] [Related]

  • 27. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.
    Zhao J, Pettigrew GJ, Thomas J, Vandenberg JI, Delriviere L, Bolton EM, Carmichael A, Martin JL, Marber MS, Lever AM.
    Basic Res Cardiol; 2002 Sep 19; 97(5):348-58. PubMed ID: 12200634
    [Abstract] [Full Text] [Related]

  • 28. Use of HIV as a gene transfer vector.
    Pluta K, Kacprzak MM.
    Acta Biochim Pol; 2009 Sep 19; 56(4):531-95. PubMed ID: 19936329
    [Abstract] [Full Text] [Related]

  • 29. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector.
    Bai Y, Soda Y, Izawa K, Tanabe T, Kang X, Tojo A, Hoshino H, Miyoshi H, Asano S, Tani K.
    Gene Ther; 2003 Aug 19; 10(17):1446-57. PubMed ID: 12900759
    [Abstract] [Full Text] [Related]

  • 30. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
    Siapati EK, Bigger BW, Miskin J, Chipchase D, Parsley KL, Mitrophanous K, Themis M, Thrasher AJ, Bonnet D.
    Mol Ther; 2005 Sep 19; 12(3):537-46. PubMed ID: 16099415
    [Abstract] [Full Text] [Related]

  • 31. Retroviral vectors for vaccine development: induction of HIV-1-specific humoral and cellular immune responses in rhesus macaques using a novel MLV(HIV-1) pseudotype vector.
    Neumann J, Stitz J, König R, Seibold E, Norley S, Flory E, Cichutek K.
    J Biotechnol; 2006 Jul 25; 124(3):615-25. PubMed ID: 16563543
    [Abstract] [Full Text] [Related]

  • 32. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
    Pellinen R, Hakkarainen T, Wahlfors T, Tulimäki K, Ketola A, Tenhunen A, Salonen T, Wahlfors J.
    Int J Oncol; 2004 Dec 25; 25(6):1753-62. PubMed ID: 15547714
    [Abstract] [Full Text] [Related]

  • 33. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM, Tisdale JF.
    Curr Hematol Rep; 2004 Jul 25; 3(4):274-81. PubMed ID: 15217557
    [Abstract] [Full Text] [Related]

  • 34. Intracellular trafficking of retroviral vectors: obstacles and advances.
    Anderson JL, Hope TJ.
    Gene Ther; 2005 Dec 25; 12(23):1667-78. PubMed ID: 16292352
    [Abstract] [Full Text] [Related]

  • 35. Safety features of retroviral vectors.
    Hansen AC, Pedersen FS.
    Curr Opin Mol Ther; 2002 Aug 25; 4(4):324-33. PubMed ID: 12222870
    [Abstract] [Full Text] [Related]

  • 36. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
    Dropulic B.
    Curr Hematol Rep; 2005 Jul 25; 4(4):300-4. PubMed ID: 16009045
    [Abstract] [Full Text] [Related]

  • 37. Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34(+) cord blood-derived dendritic cells.
    Temme A, Morgenroth A, Schmitz M, Weigle B, Rohayem J, Lindemann D, Füssel M, Ehninger G, Rieber EP.
    Gene Ther; 2002 Nov 25; 9(22):1551-60. PubMed ID: 12407427
    [Abstract] [Full Text] [Related]

  • 38. SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors.
    Berger G, Goujon C, Darlix JL, Cimarelli A.
    Gene Ther; 2009 Jan 25; 16(1):159-63. PubMed ID: 18668143
    [Abstract] [Full Text] [Related]

  • 39. Current developments in anti-HIV/AIDS gene therapy.
    Tsygankov AY.
    Curr Opin Investig Drugs; 2009 Feb 25; 10(2):137-49. PubMed ID: 19197791
    [Abstract] [Full Text] [Related]

  • 40. Transduction of human embryonic stem cells by ecotropic retroviral vectors.
    Koch P, Siemen H, Biegler A, Itskovitz-Eldor J, Brüstle O.
    Nucleic Acids Res; 2006 Feb 25; 34(18):e120. PubMed ID: 16998181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.